/Germany/EU Regulatory Notice: This communication is not intended for patients or the general public in Germany or the EU and does not constitute advertising for prescription-only medicinal products.

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most ...

CRLBF's move into Germany opens a new growth path as it navigates U.S. pricing pressure and rising competition in its core ...

CHICAGO--(BUSINESS WIRE)--Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), a vertically integrated multistate operator and the No. 1 U.S. wholesaler of branded cannabis products, today ...

The average one-year price target for Cresco Labs (OTCPK:CRLBF) has been revised to $1.68 / share. This is an increase of 10.04% from the prior estimate of $1.53 dated November 9, 2025. The price ...

Cresco Labs (OTC: CRLBF) is one of the leading companies in the marijuana industry. However, the share price of the multi-state operator has crashed by 75% over the past 12 months as the excitement ...

Cresco Labs has brought in $821 million in revenue over the trailing 12 months. This new acquisition of another strong pot company will widen Cresco's national footprint. Mergers and acquisitions are ...

Cresco Labs recently reported strong Q2-2024 financial results. The company is well positioned for growth in Florida and Pennsylvania where recreational cannabis legalization is soon expected. The ...

Cresco Labs Q1 results show higher adjusted EBITDA and improved financial performance despite a decline in revenue. Analysts have raised their outlook for Cresco Labs, projecting revenue growth in ...

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of ...

During the last three years, shares of Cresco Labs (OTC: CRLBF) lost 76% of their value. Shareholders are doubtlessly hoping that the next three years will be a lot better. Is that a realistic hope?

Cresco's retail revenue continues to grow, but its wholesale revenue isn't. The company's planned acquisition of Columbia Care will boost retail as a percent of total revenue by 12%. Cresco will also ...